What is Cogent Biosciences, Inc.'s short-term investments?

Cogent Biosciences, Inc. (COGT) reported short-term investments of $625.17M in Q1 2026.

How has Cogent Biosciences, Inc.'s short-term investments changed year-over-year?

Cogent Biosciences, Inc.'s short-term investments increased by 422.5% year-over-year, from $119.66M to $625.17M.

What does short-term investments mean?

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Cogent Biosciences, Inc. COGT Short-Term Investments

Short-Term Investments at other companies

PfizerPFE

$11.37B-28.4%

Tango TherapeuticsTNGX

$222.01M+40.3%

CG OncologyCGON

$1.04B+61.1%

CelcuityCELC

$241.87M+27.8%

Scholar RockSRRK

$49.4M-78.2%

CRISPR TherapeuticsCRSP

$2.02B+24.6%

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s short-term investments?: Cogent Biosciences, Inc. (COGT) reported short-term investments of $625.17M in Q1 2026.
How has Cogent Biosciences, Inc.'s short-term investments changed year-over-year?: Cogent Biosciences, Inc.'s short-term investments increased by 422.5% year-over-year, from $119.66M to $625.17M.
What does short-term investments mean?: Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.